Skip to main content
Premium Trial:

Request an Annual Quote

Fabric Genomics, Genomenon Sign Comarketing Deal

NEW YORK (GenomeWeb) — Fabric Genomics and Genomenon announced today that they have signed an agreement to integrate their respective genomic interpretation technologies and co-market the combined offering.

The deal will join Oakland, California-based Fabric's Enterprise platform for next-generation sequencing data analysis, interpretation, and clinical reporting with Genomenon's Mastermind literature search engine.

Last month, Ann Arbor-based Genomenon released the latest version of the Mastermind search engine, which indexes approximately 4.1 million genomic variants from supplemental data found in scientific publications.

The companies said that the integration of their technologies will allow users to see which candidate variants have any related scientific literature entries with direct access to a prioritized list of relevant articles during variant interpretation and classification.

Additional terms of the deal were not disclosed.

"Combining Fabric's algorithmic genomic analysis with Genomenon's literature search further enhances our approach to scaling genomic interpretation," Fabric President and CEO Martin Reese said in a statement. "Integrating Mastermind within our interpretation platform will help our users minimize the manual effort it takes to select and read relevant evidence-based papers."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.